The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, the Netherlands.
Development Science, UCB Biopharma SRL, Chemin du Foriest, B1420 Braine-l'Alleud, Belgium.
Drug Discov Today. 2022 Aug;27(8):2086-2099. doi: 10.1016/j.drudis.2022.04.009. Epub 2022 Apr 13.
In addition to individual imaging techniques, the combination and integration of several imaging techniques, so-called multimodal imaging, can provide large amounts of anatomical, functional, and molecular information accelerating drug discovery and development processes. Imaging technologies aid in understanding the disease mechanism, finding new pharmacological targets, and assessment of new potential drug candidates and treatment response. Here, we describe how different imaging techniques can be used in different phases of drug discovery and development and highlight their strengths, related innovations, and future potential with a focus on the implementation of artificial intelligence (AI) and radiomics for imaging technologies.
除了个体成像技术,几种成像技术的组合和整合,即所谓的多模态成像,可以提供大量的解剖学、功能和分子信息,从而加速药物发现和开发过程。成像技术有助于了解疾病机制,寻找新的药理学靶点,评估新的潜在药物候选物和治疗反应。在这里,我们描述了不同的成像技术如何在药物发现和开发的不同阶段使用,并强调了它们的优势、相关创新以及未来潜力,重点介绍了人工智能 (AI) 和放射组学在成像技术中的应用。